Exact Mass: 317.2274

Exact Mass Matches: 317.2274

Found 24 metabolites which its exact mass value is equals to given mass value 317.2274, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

MLS002608010

17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one

C20H31NO2 (317.2355)


   

3-hydroxynonanoyl carnitine

3-[(3-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H31NO5 (317.2202)


3-Hydroxynonanoyl carnitine is an acylcarnitine. More specifically, it is an 3-hydroxynonanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxynonanoyl carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxynonanoyl carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

drofenine

drofenine

C20H31NO2 (317.2355)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   
   
   

1-(1,2,3,4,5,6,7,10-octahydro-4,4,10-trimethyl-8H-benzo[e]indol-2-yl)-3-hydroxy-3-methylbutan-2-one|chamobtusin A

1-(1,2,3,4,5,6,7,10-octahydro-4,4,10-trimethyl-8H-benzo[e]indol-2-yl)-3-hydroxy-3-methylbutan-2-one|chamobtusin A

C20H31NO2 (317.2355)


   

(7aS,11aS,11bS)-7,7a,8,9,10,11,11a,11b-octahydro-11b-hydroxy-alpha,alpha,8,8,11a-pentamethyl-6H-naphth[1,2-d]azepine-4-methanol|triptotin J

(7aS,11aS,11bS)-7,7a,8,9,10,11,11a,11b-octahydro-11b-hydroxy-alpha,alpha,8,8,11a-pentamethyl-6H-naphth[1,2-d]azepine-4-methanol|triptotin J

C20H31NO2 (317.2355)


   

Trihexyphenidyl N-oxide

Trihexyphenidyl N-oxide

C20H31NO2 (317.2355)


   

Hydroxytrihexyphenidyl

Hydroxytrihexyphenidyl

C20H31NO2 (317.2355)


   
   

1-ETHYL-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

1-ETHYL-4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

C17H28BN3O2 (317.2274)


   

Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine

Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine

C20H32NP (317.2272)


   

methyl methyl undecylidene aminobenzoate

methyl methyl undecylidene aminobenzoate

C20H31NO2 (317.2355)


   

4,17alpha-Dimethyl-4-aza-5-androsten-17beta-ol-3-one

4,17alpha-Dimethyl-4-aza-5-androsten-17beta-ol-3-one

C20H31NO2 (317.2355)


   

N-(p-octylbenzoyl)-piperidin-4-ol

N-(p-octylbenzoyl)-piperidin-4-ol

C20H31NO2 (317.2355)


   

(2S)-2,6-bis[(3R)-3-aminobutanamido]hexanoate

(2S)-2,6-bis[(3R)-3-aminobutanamido]hexanoate

C14H29N4O4+ (317.2189)


   

(3Z,6Z,9Z,12Z,15Z)-N-(2-hydroxyethyl)octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-(2-hydroxyethyl)octadeca-3,6,9,12,15-pentaenamide

C20H31NO2 (317.2355)


   

3-Hydroxynonanoylcarnitine

3-Hydroxynonanoylcarnitine

C16H31NO5 (317.2202)


   

17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one

17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one

C20H31NO2 (317.2355)


   
   

1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

C20H31NO2 (317.2355)


   

(7as,11as,11bs)-4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

(7as,11as,11bs)-4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

C20H31NO2 (317.2355)


   

4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

4-(2-hydroxypropan-2-yl)-8,8,11a-trimethyl-6h,7h,7ah,9h,10h,11h-naphtho[1,2-d]azepin-11b-ol

C20H31NO2 (317.2355)


   

(3s,3ar,4s,6as,8s,11ar)-1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

(3s,3ar,4s,6as,8s,11ar)-1-hydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,8h,9h,10h-cyclohepta[d]isoindol-11-one

C20H31NO2 (317.2355)